Barclays’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$318K Buy
30,675
+16,306
+113% +$169K ﹤0.01% 3283
2025
Q1
$190K Sell
14,369
-4,730
-25% -$62.5K ﹤0.01% 3357
2024
Q4
$342K Buy
19,099
+7,488
+64% +$134K ﹤0.01% 3264
2024
Q3
$188K Buy
11,611
+7,849
+209% +$127K ﹤0.01% 3519
2024
Q2
$102K Sell
3,762
-203
-5% -$5.5K ﹤0.01% 3364
2024
Q1
$78K Sell
3,965
-2,707
-41% -$53.3K ﹤0.01% 3723
2023
Q4
$138K Buy
6,672
+4,683
+235% +$96.9K ﹤0.01% 3631
2023
Q3
$63K Sell
1,989
-52
-3% -$1.65K ﹤0.01% 3498
2023
Q2
$69K Buy
2,041
+774
+61% +$26.2K ﹤0.01% 3546
2023
Q1
$53K Hold
1,267
﹤0.01% 3775
2022
Q4
$43K Sell
1,267
-38
-3% -$1.29K ﹤0.01% 3823
2022
Q3
$64K Sell
1,305
-79
-6% -$3.87K ﹤0.01% 3578
2022
Q2
$54K Sell
1,384
-513
-27% -$20K ﹤0.01% 3705
2022
Q1
$70K Sell
1,897
-1,827
-49% -$67.4K ﹤0.01% 3841
2021
Q4
$365K Buy
3,724
+2,487
+201% +$244K ﹤0.01% 2640
2021
Q3
$155K Buy
1,237
+268
+28% +$33.6K ﹤0.01% 3084
2021
Q2
$121K Sell
969
-1,305
-57% -$163K ﹤0.01% 3077
2021
Q1
$309K Buy
2,274
+307
+16% +$41.7K ﹤0.01% 2932
2020
Q4
$178K Sell
1,967
-581
-23% -$52.6K ﹤0.01% 2747
2020
Q3
$190K Buy
2,548
+70
+3% +$5.22K ﹤0.01% 2769
2020
Q2
$210K Buy
2,478
+1,241
+100% +$105K ﹤0.01% 2786
2020
Q1
$89K Buy
+1,237
New +$89K ﹤0.01% 2875
2019
Q4
Hold
0
4164
2019
Q3
Sell
-87
Closed -$4K 4365
2019
Q2
$4K Sell
87
-235
-73% -$10.8K ﹤0.01% 4102
2019
Q1
$23K Sell
322
-100
-24% -$7.14K ﹤0.01% 3881
2018
Q4
$34K Buy
422
+197
+88% +$15.9K ﹤0.01% 3268
2018
Q3
$105K Buy
225
+181
+411% +$84.5K ﹤0.01% 3388
2018
Q2
$17K Sell
44
-53
-55% -$20.5K ﹤0.01% 3706
2018
Q1
$30K Sell
97
-4
-4% -$1.24K ﹤0.01% 3720
2017
Q4
$30K Buy
101
+45
+80% +$13.4K ﹤0.01% 3559
2017
Q3
$31K Buy
56
+4
+8% +$2.21K ﹤0.01% 3090
2017
Q2
$31K Buy
52
+51
+5,100% +$30.4K ﹤0.01% 3159
2017
Q1
$0 Buy
+1
New ﹤0.01% 4122
2016
Q4
Hold
0
3961